Key points are not available for this paper at this time.
Design
Review
Extends mechanistic understanding of autonomic arrhythmia regulation; leaves open whether NO-cGMP targeting reduces clinical events.
Cardiac sympathetic imbalance and arrhythmia; Nitric oxide-cGMP pathway and the cholinergic modulation of cardiac excitability; Nitric oxide-cGMP pathway and the sympathetic modulation of cardiac excitability; Functional significance of nitric oxide in the autonomic regulation of cardiac excitability; Summary; References. Experimental Physiology (2001) 86.1, 1-12.
No takes yet. Share an insight, caveat, or question.
David J. Paterson (2001) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: